India Launches First Generic of Merck's Zetia in U.S.

Dec 13, 2016

Economic Times

India's Glenmark Pharmaceuticals has launched the first and only generic version of Zetia -- Merck's cholesterol drug -- in the U.S. market.

Glenmark and licensing partner Endo International will be entitled to 180 days of generic drug exclusivity for ezetimibe in the U.S. market. According to IMS Health data for the 12-month period ending October 2016, annual U.S. sales of Zetia 10 mg were approximately $2.3 billion.

Glenmark, headquartered in Mumbai, has a current portfolio consisting of 111 products authorized for distribution in the U.S.

Read the ET article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments